EMA Authorised: Vaxchora (vibrio cholerae, strain cvd 103-hgr, live) — Bavarian Nordic A/S

View source ↗

Summary

The European Medicines Agency authorised Vaxchora, a live attenuated oral vaccine against cholera, manufactured by Bavarian Nordic A/S. The marketing authorizat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Vaxchora (Vibrio cholerae live attenuated vaccine (strain CV103-HGR))

Snippet

Status: Authorised. Therapeutic area: Cholera. MAH: Bavarian Nordic A/S. Decision date: 23/09/2025